期刊文献+

用α_(1A)-肾上腺素受体色谱研究哌嗪类化合物的生物亲和作用 被引量:1

α_(1A)-Adrenocepter chromatography in studying biological affinity of piperazine compounds
下载PDF
导出
摘要 目的用α1A-肾上腺素受体(α1A-AR)色谱法研究哌嗪类化合物与α1A-AR的生物亲和作用。方法采用亲和层析色谱法从家兔心脏组织中纯化得到α1A-AR,以大孔硅胶为载体,采用温和的化学偶联方法,将α1A-AR通过共价键均匀地固载在大孔硅胶表面,用盐酸特拉唑嗪、去甲肾上腺素、坦索罗辛、间羟胺和乌拉地尔表征α1A-AR色谱柱的保留特性;化学合成6种哌嗪类化合物,并用该色谱模型研究其与α1A-AR之间的相互作用关系。结果所合成哌嗪类化合物与α1A-AR之间有生物亲和作用,其亲和力大小为:化合物3>化合物4>化合物1>化合物2>化合物5>化合物6。结论α1A-AR色谱法是一种特异、可靠的生物亲和色谱方法,可用于药物活性的初步研究。 Objective To use α1A-AR(α1A-adrenocepter) chromatography for studying the biological affinity of piperazine compounds.Methods Affinity chromatography was used to purify α1A-AR obtained from rabbit heart.α1A-AR was immobilized on macroporous silica through the covalent bond by mild chemical coupling methods.The retention characteristics of α1A-AR column were investigated with terazosin,norepinephrine,tamsulosin,metaraminol,and urapidil.Six piperazine compounds were synthesized,and the interactions between the compounds and α1A-AR were investigated by the chromatographic model.Results Biological affinity was found between the synthesized piperazine compounds and α1A-AR,with the order of affinity intensities being compound 3 compound 4 compound 1 compound 2 compound 5 compound 6.Conclusion α1A-AR chromatography is a specific and reliable biological affinity chromatography and can be used for preliminary study of drug activity.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2011年第1期58-61,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(20875074/b0501)~~
关键词 肾上腺素能α1受体 哌嗪类 亲和色谱法 生物亲和作用 adrenocepter α1 piperazines affinity chromatography biological affinity
  • 相关文献

参考文献7

二级参考文献16

  • 1Khan AH, Sattar MA, Abdullah NA, et al. Influence of cisplatininduced renal failure on the alpha( 1 ) -adrenoceptor subtype causing vasoconstriction in the kidney of the rat [ J ]. Eur J Pharmaeol, 2007,569(1-2) : 110-118.
  • 2Gornemann T, yon Wenckstem H, Kleuser B, et al. Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins[J]. Br J Pharmaca, 2007,151 (2) :186-194.
  • 3Zubair K, Bexis S, Docherty JR. Relaxations to beta-adrenoceptor subtype selective agonists in wild-type and NOS-3-KO mouse mesenteric arteries[ J]. Eur J Pharmacol, 2008,587 (1-3) :216-223.
  • 4Yamaguchi O, Chapple CR. Beta3-adrenoceptors in urinary bladder [ J]. Neurourol Urodyn, 2007,26(6) :752-756.
  • 5Vytenis Arvydas Skeberdis. Structure and function of b3-adrenergic receptors[J]. Medicine Kaunas, 2004,40(5) :407-412.
  • 6Lindholm LH, Carlberq B, Samuelsson O. Should beta blockers remain first choice in treatment of primary hypertension? A meta-analysis[J]. Lancet, 2005,366(9496) :1545-1553.
  • 7Hofinouchi T, Horishima S, Tanaka T, et al. Different changes of plasma membrane be(a-adrenoceptors in rat heart 'after chronic administration of propranolol, atenolol and bevantolol [ J ]. Life Sei, 2007,81 (5) :399-404.
  • 8Lipworth B J, Williamson PA. Beta blockers for asthma: a doubleedged sword [ J ]. Lancet, 2009,10 : 373 ( 9658 ) : 104-105.
  • 9Hanania NA, Singh S, EI-Wali R, et al. The safety and effects of the beta-blocker, nadolol, in mild asthma:an open-label pilot study [ J ]. Pulm Pharmacol Ther, 2008,21 ( 1 ) :134-141.
  • 10Walker C D, Wong D T. Arylpiperazines as serotonin reuptake inhibitors and 5-HT1Da[ P]. US 6 342 498, 2002.

共引文献12

同被引文献14

  • 1张璞,李中东,焦正.第二代非典型抗精神病药——阿立哌唑[J].中国药学杂志,2005,40(3):238-240. 被引量:58
  • 2王若,关烨第.二级胺与羰基化合物的一步还原烷基化[J].高等学校化学学报,1990,11(8):894-896. 被引量:1
  • 3Waszkielewicz A M, Gunia A, Szkaradek N, et al. Syn- thesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety [J]. Bioorg Med Chem Lett,2013,2,3(15) :4419 -4423.
  • 4Hatnapure G D, Keche A P, Rodge A H, et al. Syn- thesis and biological evaluation of novel piperazine de- rivatives of flavone as potent anti-inflammatory and an- timicrobial agent [ J ]. Bioorg Med Chem Lett, 2012,22 (20) :6385 - 6390.
  • 5Selvakumar N, Rajulu G G, Reddy K C S, et al. Syn- thesis, SAR, and antibacterial activity of novel oxazo- lidinone analogues prossessing urea functionality [ J ]. bioorg Med Chem Lett,2008,18 (2) : 856 - 860.
  • 6Fan H X, Xu G, Chen Y, etal. Synthesis and antibacte- rial activity of oxazolidinones containing triazolyl group [J]. Eur J Med Chem,2007,42(8) :1137 -1143.
  • 7Jobst S, Wijngaart W, Schubert A, et al. Assessment of the eficacy and safety of three dose levels of cetiriz- ine given once daily in children with perennial allergic rhinitis [ J ]. Allergy, 1994,49 (8) :598 - 604.
  • 8Garino C, Tomita T, Pietrancosta N, et al. Naphthyl and coumaxinyl biarylpiperazine derivatives as highly potent human β-secretase inhibitors: Design, synthe- sis, and enzymatic BACE-1 and cell assays [ J ]. J Med Chem,2006,49(14) :4275 -4285.
  • 9McRobb F M, Crosby I T, Yuriev E, et al. Ho- mobivalent ligands of the atypical antipsychotic cloza- pine: Design, synthesis, and pharmacological evalua- tion [ J ]. J Med Chem,2012,55 (4) : 1622 - 1634.
  • 10隋强,唐超,刘帅,王小梅,时惠麟.齐拉西酮有关物质的合成[J].中国医药工业杂志,2012,43(12):971-973. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部